Literature DB >> 30201392

CD4+ T cell activation, function, and metabolism are inhibited by low concentrations of DMSO.

Lisa Holthaus1, Daniel Lamp1, Anita Gavrisan2, Virag Sharma3, Anette-Gabriele Ziegler4, Martin Jastroch5, Ezio Bonifacio6.   

Abstract

Dimethyl sulfoxide (DMSO) is a polar organic solvent used in a wide range of biological applications. DMSO is routinely used as a cryoprotectant for long-term cell freezing as well as to dissolve peptides and drugs for immune cell functional assays. Here, human CD4+ T cell activation, cytokine production, proliferation, and metabolism were investigated after stimulation in the presence of 0.01% to 1%, DMSO, representing concentrations commonly used in vitro. Surface expression of the activation markers CD69, CD25 and CD154 after polyclonal activation of CD4+ T cells was inhibited by 0.25% or higher concentrations of DMSO. The frequencies of IL-21+, IL-4+, and IL-22+ CD4+ T cells, following polyclonal activation were variably inhibited by DMSO at concentrations ranging from 0.25% to 1%, whereas IFNγ+ cells were unaffected. CD4+ T cell proliferation after anti-CD3 or antigen stimulation was inhibited by 0.5% DMSO and abolished by 1% DMSO. After polyclonal stimulation, glucose uptake was inhibited in the presence of 1% DMSO, but only minor effects on CD4+ T cell respiration were observed. Consistent with the immune effects, the gene expression of early signaling and activation pathways were inhibited in CD4+ T cells in the presence of 1% DMSO. Our study revealed that DMSO at concentrations generally used for in vitro studies of T cells impacts multiple features of T cell function. Therefore, we urge care when adding DMSO-containing preparations to T cell cultures.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30201392     DOI: 10.1016/j.jim.2018.09.004

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Characterization of regulatory T cell expansion for manufacturing cellular immunotherapies.

Authors:  David A McBride; Matthew D Kerr; Shinya L Wai; Yvonne Y Yee; Dora A Ogbonna; Nisarg J Shah
Journal:  Biomater Sci       Date:  2020-05-22       Impact factor: 6.843

Review 2.  Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy.

Authors:  Xue Yao; Sandro Matosevic
Journal:  BioDrugs       Date:  2021-08-24       Impact factor: 5.807

3.  STAT5 Represses a STAT3-Independent Th17-like Program during Th9 Cell Differentiation.

Authors:  D Alejandro Canaria; Bingyu Yan; Maia G Clare; Zonghao Zhang; Grace A Taylor; David L Boone; Majid Kazemian; Matthew R Olson
Journal:  J Immunol       Date:  2021-08-04       Impact factor: 5.426

4.  PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates.

Authors:  Yago Pico de Coaña; Maria Wolodarski; Irene van der Haar Àvila; Takahiro Nakajima; Stamatina Rentouli; Andreas Lundqvist; Giuseppe Masucci; Johan Hansson; Rolf Kiessling
Journal:  Oncoimmunology       Date:  2020-08-28       Impact factor: 8.110

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.